Terence Ketter

Back to Profile

Publication Details

  • Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder.

    Miller S, Ittasakul P, Wang PW, Hill SJ, Childers ME, Rasgon N, Ketter TA. J Clin Psychopharmacol. 2012; 32 (6): 814-9

    To assess longer-term ziprasidone effectiveness in obese and non-obese patients with bipolar disorder (BD).

    PubMedID: 23131875

Stanford Medicine Resources:

Footer Links: